Please assess the completion status of the following clinical trial:

Trial Title: To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 18-65years.~2. Obese BMI \>30kg/m2~3. LDL cholesterol \>100 mg/dl~4. Written and informed consent signed and dated 5. Not on any vitamin/antioxidants~Exclusion Criteria:~1. On any antilipid agents.~2. Triglyceride \>500mg/dl~3. Myocardial infarction, angioplasty/stent placement or coronary artery bypass surgery in the past 6 months~4. Patient on chronic use of non-steroidal anti-inflammatory drugs or steroids~5. Hepatic disease~6. Renal impairment~7. History of drug or alcohol abuse~8. Participation in any other concurrent clinical trial~9. Use of an investigational agent or therapeutic regimen within 30 days of study.~10. Smoker~11. Pregnancy~12. Premenopausal women who are not on birth control pills and have not had a hysterectomy or tubal ligation 13. Anemia with hemoglobin \<12 g/dl

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Placebo Arm (Type: PLACEBO_COMPARATOR): Obese subjects treated with placebo for 6 weeks
- Vytorin Arm (Type: ACTIVE_COMPARATOR): Obese subjects treated with Vytorin for 6 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).